Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.8
2.7
Journals
Brain Sciences
Special Issues
Cognitive Impairment in Neuropsychiatry
share announcement

Cognitive Impairment in Neuropsychiatry

A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Psychiatric Diseases".

Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 2278

Special Issue Editor

Prof. Dr. Pasquale Calabrese

E-Mail Website
Guest Editor
Neuropsychology and Behavioral Neurology Unit, Division of Molecular and Cognitive Neuroscience, Department of Psychology, University of Basel, Birmannsgasse 8, 4055 Basel, Switzerland
Interests: multiple sclerosis; Parkinson’s disease; dementia; depression; stress and cognition
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Cognition can be defined as the ability of processing higher level information from different sensory inputs in order to cope with everyday demands. It generally refers to mental abilities, such as attention, memory, language and mental flexibility. Cognitive impairments may occur as a consequence of distinct brain damage, but they may also arise in the context of psychiatric disorders. By recognizing that both organic, i.e., brain-damage related as well as non-organic, i.e., psychiatric diseases share the same pathological substrate, namely neuronal, biochemical and (epi-)genetic mechanisms, the resulting dysfunctions are often declared as neuropsychiatric disturbances. The range and severity of cognitive disturbances varies between psychiatric disorders, and in some conditions, cognitive alterations may even be recognized as prodromal markers.

This Special Issue aims to collate a wide array of clinical and laboratory research, including original high-quality papers, reviews as well as single case studies that elucidate the pathophysiological underpinnings, diagnosis, treatment, and the psychosocial consequences of neuropsychiatric conditions.

Prof. Dr. Pasquale Calabrese
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cognition impairment
  • multiple sclerosis
  • Parkinson’s disease
  • dementia
  • depression
  • stress and cognition
  • neuropsychiatric conditions

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

21 pages, 2257 KiB  
Article
Verbal Learning and Memory Deficits across Neurological and Neuropsychiatric Disorders: Insights from an ENIGMA Mega Analysis
by Eamonn Kennedy, Spencer W. Liebel, Hannah M. Lindsey, Shashank Vadlamani, Pui-Wa Lei, Maheen M. Adamson, Martin Alda, Silvia Alonso-Lana, Tim J. Anderson, Celso Arango, Robert F. Asarnow, Mihai Avram, Rosa Ayesa-Arriola, Talin Babikian, Nerisa Banaj, Laura J. Bird, Stefan Borgwardt, Amy Brodtmann, Katharina Brosch, Karen Caeyenberghs, Vince D. Calhoun, Nancy D. Chiaravalloti, David X. Cifu, Benedicto Crespo-Facorro, John C. Dalrymple-Alford, Kristen Dams-O’Connor, Udo Dannlowski, David Darby, Nicholas Davenport, John DeLuca, Covadonga M. Diaz-Caneja, Seth G. Disner, Ekaterina Dobryakova, Stefan Ehrlich, Carrie Esopenko, Fabio Ferrarell, Lea E. Frank, Carol E. Franz, Paola Fuentes-Claramonte, Helen Genova, Christopher C. Giza, Janik Goltermann, Dominik Grotegerd, Marius Gruber, Alfonso Gutierrez-Zotes, Minji Ha, Jan Haavik, Charles Hinkin, Kristen R. Hoskinson, Daniela Hubl, Andrei Irimia, Andreas Jansen, Michael Kaess, Xiaojian Kang, Kimbra Kenney, Barbora Keřková, Mohamed Salah Khlif, Minah Kim, Jochen Kindler, Tilo Kircher, Karolina Knížková, Knut K. Kolskår, Denise Krch, William S. Kremen, Taylor Kuhn, Veena Kumari, Junsoo Kwon, Roberto Langella, Sarah Laskowitz, Jungha Lee, Jean Lengenfelder, Victoria Liou-Johnson, Sara M. Lippa, Marianne Løvstad, Astri J. Lundervold, Cassandra Marotta, Craig A. Marquardt, Paulo Mattos, Ahmad Mayeli, Carrie R. McDonald, Susanne Meinert, Tracy R. Melzer, Jessica Merchán-Naranjo, Chantal Michel, Rajendra A. Morey, Benson Mwangi, Daniel J. Myall, Igor Nenadić, Mary R. Newsome, Abraham Nunes, Terence O’Brien, Viola Oertel, John Ollinger, Alexander Olsen, Victor Ortiz García de la Foz, Mustafa Ozmen, Heath Pardoe, Marise Parent, Fabrizio Piras, Federica Piras, Edith Pomarol-Clotet, Jonathan Repple, Geneviève Richard, Jonathan Rodriguez, Mabel Rodriguez, Kelly Rootes-Murdy, Jared Rowland, Nicholas P. Ryan, Raymond Salvador, Anne-Marthe Sanders, Andre Schmidt, Jair C. Soares, Gianfranco Spalleta, Filip Španiel, Scott R. Sponheim, Alena Stasenko, Frederike Stein, Benjamin Straube, April Thames, Florian Thomas-Odenthal, Sophia I. Thomopoulos, Erin B. Tone, Ivan Torres, Maya Troyanskaya, Jessica A. Turner, Kristine M. Ulrichsen, Guillermo Umpierrez, Daniela Vecchio, Elisabet Vilella, Lucy Vivash, William C. Walker, Emilio Werden, Lars T. Westlye, Krista Wild, Adrian Wroblewski, Mon-Ju Wu, Glenn R. Wylie, Lakshmi N. Yatham, Giovana B. Zunta-Soares, Paul M. Thompson, Mary Jo Pugh, David F. Tate, Frank G. Hillary, Elisabeth A. Wilde and Emily L. Dennisadd Show full author list remove Hide full author list
Brain Sci. 2024, 14(7), 669; https://doi.org/10.3390/brainsci14070669 (registering DOI) - 29 Jun 2024
Viewed by 368
Abstract
Deficits in memory performance have been linked to a wide range of neurological and neuropsychiatric conditions. While many studies have assessed the memory impacts of individual conditions, this study considers a broader perspective by evaluating how memory recall is differentially associated with nine [...] Read more.
Deficits in memory performance have been linked to a wide range of neurological and neuropsychiatric conditions. While many studies have assessed the memory impacts of individual conditions, this study considers a broader perspective by evaluating how memory recall is differentially associated with nine common neuropsychiatric conditions using data drawn from 55 international studies, aggregating 15,883 unique participants aged 15–90. The effects of dementia, mild cognitive impairment, Parkinson’s disease, traumatic brain injury, stroke, depression, attention-deficit/hyperactivity disorder (ADHD), schizophrenia, and bipolar disorder on immediate, short-, and long-delay verbal learning and memory (VLM) scores were estimated relative to matched healthy individuals. Random forest models identified age, years of education, and site as important VLM covariates. A Bayesian harmonization approach was used to isolate and remove site effects. Regression estimated the adjusted association of each clinical group with VLM scores. Memory deficits were strongly associated with dementia and schizophrenia (p < 0.001), while neither depression nor ADHD showed consistent associations with VLM scores (p > 0.05). Differences associated with clinical conditions were larger for longer delayed recall duration items. By comparing VLM across clinical conditions, this study provides a foundation for enhanced diagnostic precision and offers new insights into disease management of comorbid disorders. Full article
(This article belongs to the Special Issue Cognitive Impairment in Neuropsychiatry)
►▼ Show Figures

Figure 1

Review

Jump to: Research

25 pages, 594 KiB  
Review
The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
by Petru Fabian Lungu, Corina Miruna Lungu, Alin Ciobica, Ioana Miruna Balmus, Raluca Vitalaru, Ioannis Mavroudis, Romeo Dobrin, Mirela Cimpeanu and Irina Luciana Gurzu
Brain Sci. 2024, 14(4), 359; https://doi.org/10.3390/brainsci14040359 - 3 Apr 2024
Cited by 1 | Viewed by 1493
Abstract
The majority of schizophrenia-affected individuals display deficiencies in multiple cognitive domains such as attention, working memory, long-term memory, and learning, deficiencies that are stable throughout the disease. The purpose of this narrative review was to examine the effect of antipsychotics on several cognitive [...] Read more.
The majority of schizophrenia-affected individuals display deficiencies in multiple cognitive domains such as attention, working memory, long-term memory, and learning, deficiencies that are stable throughout the disease. The purpose of this narrative review was to examine the effect of antipsychotics on several cognitive domains affected by schizophrenia. Methods: We searched MEDLINE, Elsevier, Scopus, and DOAJ databases for randomized controlled trials and other studies investigating the effects of typical and atypical antipsychotics on cognition in patients with schizophrenia in studies conducted in the last decade. Results: The majority of studies included in this review showed that antipsychotics (especially SGAs) have positive effects on both cognition and general psychopathology of schizophrenia. We mention that treatment with antipsychotic substances represents an ongoing effort of the researchers, who are constantly searching for the best approach to meet the mental health needs of schizophrenia patients. Conclusions: Even with those positive results, it should be noted that more studies are needed in order to fully observe the various effects of certain antipsychotic substances on cognition. Full article
(This article belongs to the Special Issue Cognitive Impairment in Neuropsychiatry)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop